share_log

Truist Securities Maintains Hold on Fresenius Medical Care, Raises Price Target to $26

Benzinga ·  May 10, 2023 09:20

Truist Securities analyst David Macdonald maintains Fresenius Medical Care (NYSE:FMS) with a Hold and raises the price target from $24 to $26.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment